SCHEMBL4012948

SCHEMBL4012948

CCCCC1=NC(C)N(CC2CCCCC2)C=C1Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1

nearest known ligand 0.54

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SLC33A1 O00400 10/20 0.51
PPARG P37231 6/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4011452 0.96 SLC33A1 (0.52) SLC33A1PPARG
SCHEMBL4302458 0.87 LTB4R2 (0.49) SLC33A1PPARG
SCHEMBL4016596 0.86 SLC33A1 (0.50) SLC33A1PPARG
SCHEMBL4010279 0.84 AGTR1 (0.47) SLC33A1PPARG
SCHEMBL4011114 0.84 PPARG (0.48) SLC33A1PPARG
SCHEMBL4305731 0.83 PPARG (0.49) PPARG
SCHEMBL4011392 0.83 PPARG (0.49) SLC33A1PPARG
SCHEMBL4312422 0.81 PPARG (0.44) SLC33A1PPARG
SCHEMBL4009433 0.81 PPARG (0.47) SLC33A1PPARG
SCHEMBL4309643 0.79 PPARG (0.46) SLC33A1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2074117-A2 HETEROMONOCYCLIC COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2009-07-01 EP claimed
WO-2008062905-A2 HETEROMONOCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-05-29 WO claimed
WO-2009133970-A1 CRYSTALLINE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-11-05 WO disclosed
EP-2074117-A2 HETEROMONOCYCLIC COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2009-07-01 EP disclosed
WO-2008062905-A2 HETEROMONOCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-05-29 WO disclosed